Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate immune pattern-recognition and macrophage signaling pathways are fundamental systems used by the host to detect and respond to pathogens and cellular stress. These pathways are mediated by various Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), which recognize specific pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [1][2]. Upon ligand binding, these receptors initiate signaling cascades involving key adaptor proteins such as MyD88, TRIF, and MAVS, ultimately activating transcription factors like NF-κB and Interferon Regulatory Factors (IRFs) [3]. This activation leads to the production of pro-inflammatory cytokines (e.g., TNF, IL-1β, IL-6) and type I interferons, which are essential for the recruitment and activation of macrophages and other immune cells [4]. Dysregulation of these signaling pathways is implicated in a wide range of pathologies, including sepsis, chronic inflammatory disorders, autoimmune diseases, and cancer [5]. Consequently, components of these pathways are major therapeutic targets, with drugs designed to either antagonize overactive signaling in inflammatory conditions or agonize receptors to boost immune responses in oncology and vaccine development [6]. [1] Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216. [2] Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-820. [3] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373-384. [4] Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240-273. [5] Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30(1):16-34. [6] Moresco EM, LaVine D, Beutler B. The toll-like receptor signaling pathways. Cold Spring Harb Perspect Biol. 2011;3(8):a007302.
Modulation of innate immune sensors (e.g., TLRs, NLRs) and their downstream signaling components to regulate the production of pro-inflammatory cytokines and type I interferons via intracellular signaling cascades like the MyD88-dependent or TRIF-dependent pathways.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune pattern-recognition and macrophage signaling pathways (PRR signaling pathways).